Showing results (711-720 of 2,465) with videos related to

Sort By:
Pageof 247
Cancer Treatment Reviews|April 1, 2017
Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potentialMikael Larsson, Wei-Ting Huang, Dean-Mo Liu, et al.
Cancer Treatment Reviews|February 13, 2017
Clinical and biological effects of demethylating agents on solid tumours - A systematic reviewJ F Linnekamp, R Butter, R Spijker, et al.
Cancer Treatment Reviews|January 11, 2017
Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefitM Dos Santos, P E Brachet, C Chevreau, et al.
Cancer Treatment Reviews|August 23, 2019
Small cell and large cell neuroendocrine carcinoma of the larynx: A comparative analysisPrimož Strojan, Juan C Hernandez-Prera, Jonathan J Beitler, et al.
Cancer Treatment Reviews|October 2, 2022
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancerKirti K Iyer, Nielka P van Erp, Daniele V F Tauriello, et al.
Cancer Treatment Reviews|January 11, 2022
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literaturePasquale Lombardi, Daniele Rossini, Veronica Crespi, et al.
Cancer Treatment Reviews|August 29, 2022
Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature reviewJeffrey Graham, Arndt Vogel, Ann-Lii Cheng, et al.
Cancer Treatment Reviews|October 29, 2022
Toxicities following CAR-T therapy for hematological malignanciesRafael Hernani, Ana Benzaquén, Carlos Solano
Cancer Treatment Reviews|July 21, 2015
Obinutuzumab in hematologic malignancies: lessons learned to dateTim Illidge, Christian Klein, Laurie H Sehn, et al.
Cancer Treatment Reviews|August 9, 2016
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicineTania Fleitas, Maider Ibarrola-Villava, Gloria Ribas, et al.
Pageof 247